Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
202.63
-43.18 (-17.57%)
At close: Oct 22, 2026, 4:00 PM EDT
199.85
-2.78 (-1.37%)
After-hours: Oct 22, 2026, 4:59 PM EDT
Moderna Stock Forecast
Stock Price Forecast
According to 23 analysts polled by S&P Global, Moderna stock has a consensus rating of "Hold" and an average price target of $123.61. The average 1-year stock price forecast is 39.00% lower than the current stock price, while the lowest is $45 (-77.79%) and the highest is $200 (-1.30%).
Price Target: $123.61 (-39.00%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Moderna stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 4 | 4 | 4 |
| Buy | 2 | 1 | 2 | 1 | 1 | 1 |
| Hold | 16 | 17 | 16 | 17 | 15 | 14 |
| Sell | 3 | 3 | 2 | 1 | 1 | 2 |
| Strong Sell | 1 | 1 | 1 | 0 | 2 | 2 |
| Total | 24 | 24 | 23 | 23 | 23 | 23 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Sell Maintains $80 | Sell | Maintains | $80 | -60.52% | Oct 22, 2026 |
| Barclays | Barclays | Hold Maintains $125 | Hold | Maintains | $125 | -38.31% | Oct 22, 2026 |
| Bernstein | Bernstein | Hold Maintains $45 | Hold | Maintains | $45 | -77.79% | Oct 22, 2026 |
| TD Cowen | TD Cowen | Hold Maintains $40 → $90 | Hold | Maintains | $40 → $90 | -55.58% | Oct 21, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Maintains $200 → $220 | Hold | Maintains | $200 → $220 | +8.57% | Oct 19, 2026 |
Financial Forecast
Revenue This Year
2.10B
from 1.94B
Increased by 8.09%
Revenue Next Year
2.44B
from 2.10B
Increased by 16.06%
EPS This Year
-8.40
from -7.26
EPS Next Year
-4.44
from -8.40
EPS and Forward PE are based on non-GAAP adjusted numbers.